SUBSCRIBE
SUBSCRIBE
News   Business

Jack Geltosky, Ph.D. Joins Enzon Pharmaceuticals, Inc.’s Board of Directors

May 29, 2008 | 
1 min read
BRIDGEWATER, N.J.--(BUSINESS WIRE)--Enzon Pharmaceuticals, Inc. (Nasdaq: ENZN) today announced that Dr. Jack Geltosky has been appointed to the Company’s Board of Directors.
People
MORE ON THIS TOPIC
This 3D render features human icons arranged side by side and in a line. Among them, one icon at the front shines brightly, symbolizing leadership and innovation. The visual presents a powerful metaphor for leadership, innovation, and making a difference, making it ideal for themes related to leadership and inspiration in the business world.
FDA
BIO CEO Crowley, DOD doctor Overton are top candidates for FDA commissioner: RBC
June 24, 2026
 · 
3 min read
 · 
Heather McKenzie
Antares Region of the Milky Way, wide angle view
Deals
Novartis, Antares stars align in cancer deal that could top $1.9B
June 24, 2026
 · 
2 min read
 · 
Gabrielle Masson
Podcast
AbbVie keeps M&A rolling, FDA’s reversal train chugs along, BIO 2026 dispatch, more
June 24, 2026
 · 
1 min read
 · 
Jef Akst
Trustworthy and honesty to believe in work together, integrity or trust for partnership, support and reliable to help success together concept, businessman acrobat hold hand tight by trusted partner.
Mergers & acquisitions
Serapha takes reverse merger route to Nasdaq with $230M and gene editor from China
June 24, 2026
 · 
2 min read
 · 
Tristan Manalac